Fluorescein Angiography (FA) is a diagnostic imaging procedure used to visualise retinal and choroidal blood vessels with high precision. This test is essential for identifying vascular abnormalities such as leakage, non-perfusion, and neovascularisation. It is primarily used in the diagnosis of diabetic retinopathy, age-related macular degeneration (AMD), and retinal vein occlusion. According to the research paper “Prevalence Trend of Diabetic Retinopathy in India”, diabetic retinopathy affects approximately 13 million individuals in India, highlighting the clinical relevance of this imaging technique in routine ophthalmic diagnostics.
This article provides a comprehensive overview of the Fluorescein Angiography Test. It includes the definition, test’s purpose, procedural stages, interpretation of results, side effects, cost structure, top diagnostic centres in India, and viable non-invasive alternatives such as Optical Coherence Tomography Angiography (OCTA) and Indocyanine Green Angiography (ICGA).
This think-piece aims to offer a definitive and structured reference for patients, medical professionals, and researchers seeking precise and clinically validated information about Fluorescein Angiography.
What is a Fluorescein Angiography Test?
A Fluorescein Angiography Test is a diagnostic imaging procedure used to evaluate the blood vessels in the retina, the light-sensitive tissue at the back of the eye. It provides high-resolution images of retinal circulation and is essential for identifying vascular abnormalities.
The test involves an intravenous injection of fluorescein sodium, a fluorescent contrast agent. As the dye circulates through the bloodstream, it emits fluorescence under a blue light. A specialised fundus camera captures a series of images, tracking the dye’s movement through the retinal and choroidal vasculature.
This test is used to detect pathological features such as vascular leakage, microaneurysms, ischemic zones, neovascularisation, and vessel blockage. These findings support diagnosing and monitoring conditions such as diabetic retinopathy, age-related macular degeneration (AMD), retinal vein occlusion, macular oedema, and inflammatory retinal diseases as in the image below.
Fluorescein angiography enables ophthalmologists to visualise retinal blood flow in real time. This dynamic assessment allows for early detection of abnormalities, evaluation of disease progression, and formulation of targeted treatment strategies.
Why is a Fluorescein Angiography Test Performed?
A Fluorescein Angiography Test is performed to detect and monitor pathological changes in the retinal vasculature. It enables direct visualisation of blood flow and vascular integrity, supporting the diagnosis of several retinal disorders.
The test identifies capillary non-perfusion, vessel leakage, and neovascularisation, which are characteristic findings in diabetic retinopathy. It also reveals choroidal neovascular membranes and subretinal fluid associated with age-related macular degeneration (AMD).
Additional conditions diagnosed using this test include retinal detachment, macular oedema, retinal vascular occlusions, intraocular tumours, and ocular infections with vascular involvement.
Beyond diagnosis, fluorescein angiography is used to evaluate therapeutic response. It tracks structural changes in the vasculature following interventions such as intravitreal injections or laser photocoagulation. This enables timely modification of treatment protocols and supports long-term disease management.
How is the Fluorescein Angiography Test Done?
Fluorescein Angiography is performed by injecting fluorescein dye into a vein and capturing sequential retinal images as the dye circulates through the eye’s blood vessels.
The procedure is conducted in three stages: Before the Test (preparation and medical disclosures), During the Test (dye injection and image capture), and After the Test (post-test effects and precautions). Each stage plays a critical role in ensuring diagnostic accuracy and patient safety.
Before the Test
Patients must disclose any known allergies, current medications, or pregnancy status. These factors influence eligibility for fluorescein administration. Clinical staff provide procedural instructions and obtain informed consent. Pupillary dilation is initiated using topical mydriatic agents to ensure optimal retinal imaging.
During the Test
The procedure begins with the intravenous injection of fluorescein sodium, typically into a peripheral vein in the arm. A fundus camera equipped with excitation and barrier filters captures sequential images of the retinal vasculature as the dye circulates. The imaging process lasts 10-20 minutes. Patients may report a transient warm sensation or metallic taste during dye administration.
After the Test
Following image capture, patients may observe yellow-orange discolouration of the skin and urine, which resolves as the dye is cleared renally within 24 hours. Mild nausea may occur immediately after injection. Normal activities can resume shortly after the procedure. Post-test instructions include avoiding intense sunlight exposure and increasing fluid intake to expedite dye elimination. Any persistent or severe symptoms must be reported to a healthcare provider.
How to Interpret Fluorescein Angiography Results?
Fluorescein Angiography results are interpreted by evaluating the pattern, timing, and intensity of dye distribution within the retinal and choroidal vessels.
A normal result shows uniform fluorescence within retinal arteries and veins, without leakage, blockage, or abnormal fluorescence intensity. The vessels display continuous flow, regular calibre, and intact borders, indicating stable vascular integrity.
Abnormal results include findings such as:
- Dye leakage is observed as hyperfluorescence, indicating increased vascular permeability, and is commonly associated with diabetic retinopathy or macular oedema.
- Vessel blockage appears as areas of non-perfusion or hypofluorescence and is consistent with retinal vein occlusion or arterial obstruction. Neovascularisation is identified by late-phase hyperfluorescence, caused by abnormal vessel proliferation, and is characteristic of proliferative diabetic retinopathy or wet age-related macular degeneration (AMD).
Follow-up evaluation is indicated when abnormal patterns are detected. This includes optical coherence tomography (OCT), indocyanine green angiography (ICGA), or additional fundus imaging to confirm diagnosis and assess severity. Treatment strategies, such as anti-VEGF injections, laser photocoagulation, or vitrectomy, are selected based on lesion type and extent.
Regular imaging is essential for monitoring disease progression and evaluating therapeutic outcomes. Early identification of vascular anomalies significantly improves visual prognosis.
How Long Does Fluorescein Angiography Last?
The Fluorescein Angiography procedure itself typically lasts about 10-20 minutes. This includes the fluorescein angiography procedure, which lasts approximately 10 to 20 minutes. This duration includes the intravenous injection of fluorescein sodium and the capture of sequential retinal images.
The full clinical appointment, including pre-test preparation and post-test guidance, typically spans 45 to 60 minutes. Image acquisition is followed by immediate observational monitoring before discharge.
Fluorescein dye is metabolised and excreted via the kidneys within 24 hours. Temporary yellow-orange discolouration of the skin and urine is expected during this elimination phase.
Captured angiographic images are analysed by an ophthalmologist within a variable timeframe, depending on case complexity and facility workflow. Diagnostic interpretation is usually provided during a follow-up consultation or on the same day at high-volume centres.
While the procedure is brief, patients should allocate additional time to accommodate the administrative, clinical, and interpretive components of the testing process.
What are the Side Effects of Fluorescein Angiography?
Fluorescein Angiography may cause both common and rare side effects. As a result, the procedure is unsuitable for individuals with specific medical conditions or risk factors.
Common Side Effects
The most frequently observed effects are:
- Transient nausea occurs immediately after intravenous dye injection.
- Warm flushing sensation, typically lasting a few seconds during dye circulation.
- Yellow-orange discolouration of the skin and urine, resulting from renal dye excretion. This resolves within 24 hours without intervention.
These effects are self-limiting and do not require clinical treatment.
Rare but Serious Risks
Serious adverse events are infrequent but medically significant:
- Systemic hypersensitivity reactions, including urticaria (rash), pruritus (itching), or bronchospasm.
- Anaphylaxis, presenting as acute respiratory distress, hypotension, and loss of consciousness, requires emergency intervention.
- Dyspnea, especially in individuals with pre-existing pulmonary conditions.
The incidence of severe reactions is extremely low, estimated below 1%, but necessitates immediate clinical management when present.
Who Should Not Undergo the Test
Fluorescein Angiography is not recommended for:
- Pregnant individuals are at risk due to the potential risk to fetal development.
- Patients with known allergies to fluorescein dye should avoid exposure, as exposure may trigger severe reactions.
- Individuals with impaired kidney function, since delayed dye clearance may lead to systemic accumulation.
In these cases, non-invasive alternatives such as Optical Coherence Tomography Angiography (OCTA) or Indocyanine Green Angiography (ICGA) are preferred.
How Much Does Fluorescein Angiography Cost?
The cost of Fluorescein Angiography in India typically ranges between ₹2000 and ₹5000 per session. This variation is influenced by several operational and clinical factors such as the type of facility, imaging equipment, clinical expertise, and other inclusions. Each of them is briefly explained below in terms of how it impacts the cost.
- Type of facility: Private hospitals and speciality eye centres generally charge more than diagnostic clinics or government institutions.
- Imaging equipment: Advanced fundus cameras and high-resolution angiography systems increase procedural costs.
- Clinical expertise: Procedures performed by senior ophthalmologists or retina specialists may incur higher consultation and interpretation fees.
- Inclusions: The total cost may cover pupil dilation, ophthalmic consultation, and post-test counselling. In some cases, it is bundled with other imaging tests.
Fluorescein Angiography is eligible for reimbursement under many private health insurance policies, subject to diagnostic necessity and plan terms.
Costs should be evaluated based on imaging quality, physician credentials, and diagnostic accuracy when selecting a testing facility.
What are the Top Fluorescein Angiography Test Centres?
Fluorescein Angiography is performed at various accredited medical institutions across India, including government hospitals, public ophthalmology departments, and select private speciality centres. Among these, the following centres have been ahead of the curve consistently:
Eye7 Eye Hospitals offer high-resolution digital fluorescein angiography in Delhi NCR with standardised protocols across NABH-accredited centres. Retinal imaging is conducted by certified specialists with rapid result turnaround and advanced diagnostic integration.
AIIMS, New Delhi, provides fluorescein angiography through its tertiary ophthalmology unit, primarily for complex and referred cases. The service is subsidised and follows evidence-based academic protocols.
Sankara Nethralaya in Chennai is a government-aided institute that performs fluorescein angiography under its public-care model with structured diagnostic workflows. Subsidised testing is available but may involve longer wait times.
Regional Institute of Ophthalmology is a government facility in Kolkata that offers fluorescein angiography as part of state-funded care programs. Imaging services are supervised by consultants and prioritised based on clinical urgency.
What are the Alternatives to Fluorescein Angiography?
Several imaging techniques, such as Optical Coherence Tomography Angiography (OCTA), Indocyanine Green Angiography (ICGA), and Fundus Photography, are available as alternatives to Fluorescein Angiography. Descriptions of each are provided below, particularly for cases where the procedure is contraindicated or when a non-invasive evaluation is preferred.
OCTA is a non-invasive imaging technique that provides high-resolution, cross-sectional views of the retinal and choroidal vasculature without the use of dye. It is preferred in patients with dye allergies, renal impairment, or during pregnancy.
ICGA uses indocyanine green dye, which fluoresces in the near-infrared spectrum, allowing visualisation of deeper choroidal vessels. It is selected when evaluating pathologies such as polypoidal choroidal vasculopathy or choroiditis, where deeper imaging is necessary.
Fundus photography captures static, surface-level images of the retina using visible light. It is used for documenting structural abnormalities but lacks the vascular detail and dynamic flow information offered by angiographic techniques.
These alternatives are selected based on diagnostic objectives, patient tolerance, and contraindications to fluorescein dye.
Resources
- https://www.researchgate.net/publication/352124305_Prevalence_Trend_of_Diabetic_Retinopathy_in_India